Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 2 (50%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, CHIHYI NMN | 1 | 32.9% | +58.5% |
| BURKHART, MICHAEL D | 1 | 62.2% | +11.5% |
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| MEYERING, SHABANA SHABBEER | 1 | 69.2% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017636 | 5' S/MAR APPLICATIONS | BURKHART, MICHAEL D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275978 | MAP4K1 INHIBITORS | LEE, CHIHYI NMN | — |
| 18017636 | 5' S/MAR APPLICATIONS | BURKHART, MICHAEL D | — |
| 17787855 | LEUKEMIA TREATMENT | AEDER, SEAN E | — |
| 16648768 | NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS | MEYERING, SHABANA SHABBEER | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1638 | 1 |
| 1642 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18275978 | MAP4K1 INHIBITORS | LEE, CHIHYI NMN | 1628 | §103§112DP | Non-Final OA | — | Pending | Aug 04, 2023 |
| 18017636 | 5' S/MAR APPLICATIONS | BURKHART, MICHAEL D | 1638 | §102§103 | Non-Final OA | — | Pending | Jan 23, 2023 |
| 17787855 | LEUKEMIA TREATMENT | AEDER, SEAN E | 1642 | §103 | Final Rejection | — | Pending | Jun 21, 2022 |
| 16648768 | NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS | MEYERING, SHABANA SHABBEER | 1635 | §103DP | Non-Final OA | — | Pending | Mar 19, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial